Medical equipments, pharmaceuticals and personal care products | Tenderlake

Medical equipments, pharmaceuticals and personal care products

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
26 October 2021
Closing Date:
08 November 2021
Location(s):
PL POLSKA (PL Poland/POLSKA)
Description:
Delivery of medicinal products, medical devices, cosmetics with a division of 107 tasks

3.1. The subject of the order is the delivery of:

- medicinal products

- medical devices

- toiletries

according to:

By Act of 6 September 2001 Pharmaceutical Law (Journal of Laws of 2020, item 944),

By Law of 20 May 2010 on Medical Devices (i.e. Journal of Laws of 202020r, item 186),

- Regulation of the Minister of Health of 16 September 2010 (uniform text: Journal of Laws of 2015, item 1026, as amended),

Aciclovirum

fiol. 250 mg 5 /80

Voriconazolum

tabl.powl.200 mg 28/30

Lorlatinibum

Table. powl. 100 mg 30/5

Deferazrox

tabl.powl.360 mg 30/30

cisatracurium

amp.10 mg 5/30

HYDROGENIUM PEROXYDATUM 30%

Op.1000 g. 1/20

LYDOCAINI HYDROCHLORIDUM

viol. 20 mg/1ml-50ml 5/60

LYDOCAINI HYDROCHLORIDUM 2%

gel type U op.30 g 1/1000

PHENYLEPHRINUM

amp. 10 mg/ 1 ml 25/1

Voriconazolum

viol.200 mg 1/100

High protein three-ventricular bag dedicated to the Intensive Care Unit, used during continuous renal replacement therapy to compensate for amino acid loss on the filter.

High protein three-ventricular bag dedicated to the Intensive Care Unit, used during continuous renal replacement therapy to compensate for amino acid loss on the filter. The ratio of non-protein energy to nitrogen is 53 kcal/g N. Coverage of the daily protein requirement up to 2g/kg/day

(12 g N /1000 ml). Bag 1000 ml 6/10

MOISTURIZING INTIMATE GEL FOR WOMEN WITH CONSISTENCY ALLOWS APPLICATION TO THE CATHETER (IT CAN NOT HAVE THE CONSISTENCY OF A DENSE GEL. Application from a tube easy to one-time squeeze.

gel op.Application only with a tube 40 g or 40 ml swap for another form not allowed 1/300

Cytarabinum

viol. 1g/20ml 1/150

Filgrastimum

ampstrz. 48 million/0.5 ml 1/100

IMATINIBUM to be reimbursed in tumor - advanced nodular fibroosarcoma

tabl.powl. 400mg 30/100

Ipilimumab

viol. 50 mg 1/200

WISMODEGIBUM

hard caps. 150 mg 28/30

Acidum folicum

Table 5 mg 30/25

Amphotericinum B

oral suspension 40 ml 1/30

ALLOPURINOLUM

Table 100 mg 50/100

AZTREONAMUM

fiol. 1 g 1/120

Caspofunginum

viol. 50 mg 1/30

Caspofunginum

viol. 70 mg 1/3

Ceftazidimum + Avibactamum

fiol. 2 g + 0.5 g 10/13

Ciclosporinum

caps. elast. 50 mg 50/2

Ciclosporinum

caps. elast. 100 mg 50/2

Cidofovir

fiol. 375 mg 1/3

Ciclosporinum

oral solution 50 ml 1/2

CLEMASTIUM

Table 1 mg 30/70

Cyanocobalaminum

amp 1000 mcg 5/10

COLISTIMETHATUM NATRICUM

powder vial 1 000 000 UU 20/60

DEFEROXAMINI MESILAS

fiol. 500 mg 10/5

DEXAMETHASONUM

tab.20 mg 20/8

GANCICLOVIRUM

fiol. 500 mg 5/35

IMMUMOGLOBULINA KRENERAL v PEOPLE LIMFOCYTOM t

vial 100 mg/5 ml 10/10

ITRACONAZOLUM

Caps. 100 mg 28/10

METHOXSALENUM

amp. 20 mcg/ml 50/2

Methylprednisolonum

Table 4 mg 30/8

Methylprednisolonum

Table 16 mg 30/8

Methylprednisolonum

viol.1000 mg 1/15

Methylprednisolonum

viol. 40 mg 1/300

Dexmedetomidinum

fiol.400 mcg 4/ 40

Methylprednisolonum

viol.125 mg 1/20

Methylprednisolonum

viol. 250 mg 1/100

Methylprednisolonum

fiol. 500 mg 1/30

Methylprednisolonum

fiol. 1000 mg 1/30

PREDNISONUM

Table 20 mg 20/120

SIROLIMUSUM

Tabl. irritated 1 mg 30/10

VALGANCICLOVIRUM

Table. powl. 450 mg 60/3

BLINATUMOMABUM

fiol.38.5 mcg 1/10

BUSULFANUM

viol. 60 mg 8/20

CARMUSTINE

viol. 100 mg 1/40

FENTANYLUM for administration i.m, i.v., s.c., epidural, subarachnoid

amp.500 mcg/10ml 50/20

Chlorambucilum

Table. powl. 2 mg 25/4

Ciclosporinum

amp. 50 mg/ml 10/120

DARATUMUMABUM

fiol. 400 mg/20 ml 1/15

Daunorubicinum

viol. 20 mg 1/100

ELTHROMBOPAGUM

Table. powl. 50 mg 28/15

Epoetinum beta

pre-filled syringe 30 000 Um/0.6ml 1/10

Fludarabinum

viol. 50 mg 5/10

Hydroxycarbamide

caps. hard 500 mg 100/2

Immunoglobulinum humanum - Preparation with a content of IgG at least 98%; IgA max 280µg/ml

fiol. 1 gram 1/600

Infliximabum

viol. 100 mg 1/10

HEPARINUM NATRICUM with a minimum of 250 U/1g

gel; Op. 100 g. 1/50

INOTUZUMABUM OZOGAMICINI

viol. 1 mg 1/15

Lamivudinum

Table. powl. 100 mg 28/3

MELPHANALUM

tabl.powl. 5 mg 25/6

Melphalanum

viol. 50 mg 1/60

Pegasparagasum

fiol. 3750 IU/5ml 1/2

Peginterferonum alpha-2a

pre-filled syringe 90 mcg/0,5ml 1/18

Pomalidomidum

caps. hard 4 mg or caps.hard 3 mg or caps.hard 2 mg or caps.hard 1 mg 21/2

Ponatinibum

Table. powl. 45 mg in a pack of 30 pcs.or tabl.powl.15 mg pc.60 pcs. 30 or 60 according to the description of co.4 /3

Thalidomidum

Table 100 mg 30/20

Carfilzomibum

viol.10 mg 1/100

Oxycodoni hydrochloridum

amp. 50mg/1 ml 5/30

PHEDRATINIBUM

caps.hard 100 mg 120/4

Luspaterceptum

fiol.75 mg 1/15

Micafunginum

fiol. 100mg 1/15

Mycophenolate mofetil

tabl.powl. 500 mg 50/6

Mycophenolate mofetil

viol.500 mg 4/15

Plerixafor

viol.24mg/1.2ml 1/6

Anagrelidum

caps.hard 1mg 100/40

Azacitidine

viol.100 mg/ 4ml 1/350

Bosutinibum

tabl.powl.500 mg 28/15

Brentuximabum vedotinum

viol.50 mg 1/60

THIOPENTAL or THIOPENTALUM

500 mg vial 10/20

Dasatinibum

Table. powl. 20 mg 60/5

Dasatinibum

tabl. powl.140 mg 30/3

Dasatinibum

Table. powl. 50 mg 60/3

Dasatinibum

Table. powl. 80 mg 30/5

Human immunoglobulin 10% for subcutaneous administration included with recombinant human hyaluronidase

IG 10% vial 30g + rHuPH20, 2/30

Immunoglobulins intravenous, 10% solution, IgG content ≥ 98%, IgA content ≤ 0,14 mg/ml

fiol.5g 1/250

Immunoglobulinum humanum for subcutaneous administration with a content of 1, IgG at least 95% 2.IgA max 50ug/ml, viol.≤ 0.2 g/ml

gram 1/340

Lenalidomidum

caps.hard 5 mg 21/10

Lenalidomidum

caps.hard 10 mg 21/10

Lenalidomidum

caps.hard 15 mg 21/10

Tigecyclinum

vial 50 mg 10/30

Nillotinbum

caps.hard 200mg 112/15

Posaconazolum

Suspension. Oral 40mg/ml op 105 ml 1/50

Rasburicasum

amp.1.5 mg 3/50

Ruxolitinibum

tabl.5 mg 56/10

Ruxolitinibum

tabl.15 mg 56/5

Ruxolitinibum

tabl.20 mg 56/25

Voriconazolum

tabl. powl.200 mg 20/60

Vedolilizumabum

viol.300 mg 1/8

AVELUMABUM

viol.200 mg 1/30

Dacomitinibum

tabl. powl. 45 mg or tabl.powl. 30 mg.or tabl.powl.15 mg 30/5

Download full details as .pdf
The Buyer:
DOLNOŚLĄSKIE CENTRUM ONKOLOGII WE WROCŁAWIU
CPV Code(s):
33000000 - Medical equipments, pharmaceuticals and personal care products